Drug intelligence / Profile preview

Chai-Shi-Xiao-Pi-Tang

Development stage: Preclinical
Lead developer: Tongde Hospital of Zhejiang Province
Administration: Oral

Overview

Chai-Shi-Xiao-Pi-Tang is a Traditional Chinese Medicine (TCM) formula currently undergoing clinical investigation for its potential in treating postoperative cancer-related fatigue in patients with colorectal cancer. The specific composition and detailed mechanism of action of this particular formulation are not publicly detailed in the provided context or general search results.

Beyond the preview

Go deeper on Chai-Shi-Xiao-Pi-Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chai-Shi-Xiao-Pi-Tang.

Explore the full profile